🇺🇸 FDA
Company

BridgeBio

BridgeBio Oncology Therapeutics

BBOT pharma USA

Quick answer

BridgeBio is a pharma company (BBOT) headquartered in SOUTH SAN FRANCISCO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

AG10

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Phase 3 · small_molecule · terminated

1 trials project

ALXN2060

Symptomatic Transthyretin Amyloid Cardiomyopathy

Phase 3 · small_molecule · completed

1 trials project

Acoramidis

Amyloidosis

Phase 3 · small_molecule · active

3 trials project

Acoramidis

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Phase 3 · small_molecule · terminated

1 trials project

Acoramidis (AG10)

Amyloidosis in Transthyretin (TTR)

Phase 3 · small_molecule · active

1 trials project

Acoramidis (AG10)

Amyloid Cardiomyopathy, Transthyretin-Related

Phase 3 · small_molecule · active

1 trials project

BGJ398

Advanced Cholangiocarcinoma

Phase 3 · small_molecule · terminated

1 trials project

Encaleret

Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Phase 3 · small_molecule · active

1 trials project

Encaleret

Autosomal Dominant Hypocalcemia (ADH)

Phase 3 · small_molecule · active

2 trials project

Infigratinib

Upper Tract Urothelial Carcinomas

Phase 3 · small_molecule · terminated

1 trials project

Infigratinib 0.25 mg/kg/day

Achondroplasia

Phase 3 · small_molecule · completed

1 trials project

infigratinib 0.128 mg/kg/day

Hypochondroplasia

Phase 3 · small_molecule · active

1 trials project

AG10

Familial ATTR-CM (ATTRm-CM, or FAC)

Phase 2 · small_molecule · completed

1 trials project

AG10

Amyloid Cardiomyopathy

Phase 2 · small_molecule · active

1 trials project

BGJ398 (infigratinib)

Advanced Cholangiocarcinoma

Phase 2 · small_molecule · terminated

1 trials project

Infigratinib

Hypochondroplasia

Phase 2 · small_molecule · active

1 trials project

Infigratinib

Achondroplasia

Phase 2 · small_molecule · active

1 trials project

Infigratinib 0.016 mg/kg

Achondroplasia

Phase 2 · small_molecule · completed

1 trials project

Infigratinib is provided as a single dose of minitablets for oral administration

Achondroplasia

Phase 2 · small_molecule · active

1 trials project

PTR-01

Recessive Dystrophic Epidermolysis Bullosa

Phase 2 · small_molecule · completed

1 trials project

VT30

Venous Malformation

Phase 2 · small_molecule · terminated

1 trials project

encaleret

Post-Surgical Hypoparathyroidism

Phase 2 · small_molecule · completed

1 trials project

AG10 oral tablet

Amyloid Cardiomyopathy, Transthyretin-Related

Phase 1 · small_molecule · completed

1 trials project

BBO-10203

Solid Tumor, Adult

Phase 1 · small_molecule · active

1 trials

Drugs (1)

drug

acoramidis hydrochloride

ATTRUBY

Patents (1)

patent

US 12427111

Lipid nanoparticles

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)